Stocks
Health Care
slno
Soleno Therapeutics
NASDAQ: SLNO
+12.77 (+32.34%)
52.26
USD
At close at Apr 06, 20:41 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-184.43M
Pretax Income
20.89M
Net Income
-175.85M
EBITDA
-173.19M
EBIT
-175.62M
Earnings Per Share
-4.29
Balance Sheet
Cash & Cash Equivalents
59.05M
Total Debt
14.12M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
233.49M
Book Value Per Share
6.32
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.